ArticleJournal of pharmacy & bioallied sciences2025

Enhancing Tuberculosis Diagnosis and Treatment Monitoring: Evaluating Ki67 and HLA-DR Biomarkers Via Point-of-Care Testing and Comparative Analysis of Flow Cytometry Versus ELISA in Whole Blood Samples.

Mohammad Ilyas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.